|
|
Volumn 59, Issue 9, 1998, Pages 484-495
|
|
Update on the management of bipolar illness
a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
ANTICOAGULANT AGENT;
ANTICONVULSIVE AGENT;
BENZODIAZEPINE;
CARBAMAZEPINE;
CLONAZEPAM;
CLOZAPINE;
CONTRACEPTIVE AGENT;
GUANINE NUCLEOTIDE BINDING PROTEIN;
LAMOTRIGINE;
LITHIUM;
LORAZEPAM;
MONOAMINE OXIDASE INHIBITOR;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEUROLEPTIC AGENT;
OLANZAPINE;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
TOPIRAMATE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROATE SEMISODIUM;
ADOLESCENT;
ADULT;
ATTENTION DEFICIT DISORDER;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DIABETES INSIPIDUS;
DRUG INDUCED DISEASE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MANIA;
MANIC DEPRESSIVE PSYCHOSIS;
MENTAL DISEASE;
MOOD;
MULTICENTER STUDY;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RASH;
REVIEW;
SEDATION;
SUICIDE ATTEMPT;
TREATMENT OUTCOME;
|
|
EID: 0031691537
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.v59n0909 Document Type: Review |
|
Times cited : (4)
|
|
References (10)
|